We are live on
!
Find out more
FOLD
Amicus Therapeutics
FOLD
FOLD
Delisted
FOLD was delisted on the 24th of April, 2026.
332 hedge funds and large institutions have $4.57B invested in Amicus Therapeutics in 2025 Q4 according to their latest regulatory filings, with 97 funds opening new positions, 112 increasing their positions, 85 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
16% more funds holding
Funds holding: 287 → 332 (+45)
2.77% more ownership
Funds ownership: 101.3% → 104.07% (+2.8%)
19% less call options, than puts
Call options by funds: $18.8M | Put options by funds: $23.1M
Holders
332
Holding in Top 10
13
Calls
$18.8M
Puts
$23.1M
Top Buyers
| 1 | +$150M | |
| 2 | +$113M | |
| 3 | +$105M | |
| 4 |
BlackRock
New York
|
+$65.6M |
| 5 |
SFM
Soros Fund Management
New York
|
+$49.1M |
Top Sellers
| 1 | -$268M | |
| 2 | -$118M | |
| 3 | -$86.6M | |
| 4 |
VPC
Vestal Point Capital
New York
|
-$76.8M |
| 5 |
William Blair Investment Management
Chicago,
Illinois
|
-$50.3M |
